Hospital Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth Opportunities, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2022 to 2030
The Hospital Injectable Drugs Market is projected to grow from USD 38.7 billion in 2021, at a CAGR of around 4.8% during the forecast period.
Global Hospital Injectable Drugs Market Overview:
The pharmaceutical sector is growing at a significant rate due to increasing prevalence of the disease, raising awareness and increasing government initiatives. Injectable drugs refer to drugs that are introduced into the patient's body with the help of an injection.
It is injected directly into the bloodstream using injectable devices such as syringes and needles. Based on formulation, the injectables market can be segmented into microspheres, liposomes, and nanoparticles.
North America dominates the global market for hospital injectables due to high demand for pharmaceuticals and technological advancements in the region. Following Asia, Europe is expected to experience high growth rates in the coming years in the global hospital injectables market.
This is due to improved healthcare facilities and increased R&D initiatives in the region. Countries such as Brazil, Russia, China, and India are expected to be the fastest-growing hospital injectables markets. Some of the major driving forces for the hospital injectables market in emerging countries are the large patient pool and rising standard of care in this area.
Awareness and technological advances in this field are driving the global hospital injectables market. Additionally, the improved efficacy demonstrated by this class of drugs, increased prevalence of chronic diseases and improvements in healthcare facilities are driving the hospital injectables market.
However, some of the major factors limiting the global hospital injectables market are stringent government regulations in some countries and lack of experienced healthcare professionals.
The emergence of innovative new drugs such as biosimilars is expected to be a good opportunity for the hospital injection market. Emerging markets also have great growth potential for the hospital injectables market. Side effects and patent expiry of various injectables are challenges facing the hospital injectables market.
Hospital Injectable Drugs market size, estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Hospital Injectable Drugs market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and the Russian-Ukraine war.
Major Market Segments Covered in Hospital Injectable Drugs Market Research:
Market Key Players:
Baxter International Inc., Sanofi, Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Gilead, And Others.
- Generic Sterile Injectables
- Sterile Intravenous (IV) Solutions
- Cardiology & Metabolic disorders
- Infectious Diseases
By End-Use Type:
- Hospital Pharmacy
- Retail Pharmacy
By region, North America accounted for the largest market share in 2020 and is projected to grow at a solid CAGR during the review period. This can be attributed to the high adoption rate of advanced diagnostic equipment combined with the presence of key market players such as Kemper Medical, Inc. (US) and Chemyx, Inc. (US). Market growth in the Asia-Pacific region is expected to be driven by increasing adoption of hospital injectable drugs in diagnostic procedures, especially in developing countries.
- North America
- Rest of North America
- The Netherlands
- Nordic Countries
- Benelux Union
- Rest of Europe
- Rest of Southeast Asia
- South Korea
- Southeast Asia
- Rest of Asia-Pacific
- The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Rest of Latin America
Hospital Injectable Drugs Market Report Scope:
CAGR of 4.78% from 2022 to 2030.
|Generic Sterile Injectables, Sterile Intravenous (IV) Solutions|
Hospital Pharmacy, Retail Pharmacy, E-commerce
Baxter International Inc., Sanofi, Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Gilead
Regions and Countries Covered
2017 to 2022
2023 to 2030
Crucial Points from this Hospital Injectable Drugs Market Report
- Estimate Hospital Injectable Drugs market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, applications and by different industry verticals.
- Understand the supply chain in depth on the value growth at each step, in order to optimize value and bring effectiveness in your processes.
- Know the different dynamics affecting the market - challenges, key driving factors and opportunities.
- Get a quick viewpoint on the Hospital Injectable Drugs market entropy - M&A's, deals, partnerships, product launches of all key companies for the historical 5 years.
- Estimate the supply-demand gaps, import-export data and regulatory landscape for more than top 20 countries worldwide for the market.
- Get complete insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
- Study the sales and distribution channels over key geographies to improve top-line revenues.
Frequently Asked Questions-
What is the CAGR of Hospital Injectable Drugs market?
The Hospital Injectable Drugs Market is growing at a CAGR of 4.78% During Forecast Period.
What are the key types of Hospital Injectable Drugs market?
Generic Sterile Injectables, Sterile Intravenous (IV) Solutions
What are the key applications of Hospital Injectable Drugs market?
Hospital Pharmacy, Retail Pharmacy, E-commerce
Who are the key players in Hospital Injectable Drugs market?
Baxter International Inc., Sanofi, Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Gilead, and others.